| scholarly article | Q13442814 |
| P50 | author | Uta Ceglarek | Q64975403 |
| P2093 | author name string | Thomas Pabst | |
| Jeffrey R Idle | |||
| Linda Kortz | |||
| Georg M Fiedler | |||
| Diren Beyoğlu | |||
| P2860 | cites work | Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency | Q22010457 |
| The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease | Q28141040 | ||
| Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group | Q28296408 | ||
| Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity | Q28369342 | ||
| Enzymatic inactivation of leukotriene B4 by a novel enzyme found in the porcine kidney. Purification and properties of leukotriene B4 12-hydroxydehydrogenase | Q28623377 | ||
| Loss of 15-hydroxyprostaglandin dehydrogenase indicates a tumor suppressor role in pituitary adenomas | Q28771378 | ||
| Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction | Q33561797 | ||
| ABC transporters in lipid transport | Q33944775 | ||
| The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane | Q34074379 | ||
| Eicosapentaenoic acid (EPA): an antiinflammatory omega-3 fat with potential clinical applications | Q34105483 | ||
| Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples. | Q34159086 | ||
| Coenzyme Q and the regulation of intracellular steady-state levels of superoxide in HL-60 cells | Q34551992 | ||
| Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group | Q34692984 | ||
| Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology | Q34765395 | ||
| Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling | Q35501184 | ||
| Biological activities and mechanisms of action of PGJ2 and related compounds: an update | Q35531399 | ||
| The MRP family of drug efflux pumps | Q35567296 | ||
| Endogenous Production of Long-Chain Polyunsaturated Fatty Acids and Metabolic Disease Risk | Q36071775 | ||
| Disruption of tumor suppressor gene Hint1 leads to remodeling of the lipid metabolic phenotype of mouse liver. | Q36196812 | ||
| Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients | Q36324321 | ||
| Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification | Q36849666 | ||
| The production and composition of rat sebum is unaffected by 3 Gy gamma radiation | Q36979312 | ||
| Role of the endocannabinoid system in diabetes and diabetic complications | Q37085532 | ||
| Cancer metabolism: fatty acid oxidation in the limelight | Q37155867 | ||
| The role of the CB1 receptor in the regulation of sleep | Q37178101 | ||
| Prevalence of transient hyperglycemia and diabetes mellitus in pediatric patients with acute leukemia | Q37692777 | ||
| Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia | Q38641714 | ||
| Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias. | Q38843506 | ||
| Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cells. | Q38872245 | ||
| ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers. | Q39005733 | ||
| Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes | Q39848851 | ||
| P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors | Q40070493 | ||
| Cholesterol, phospholipids, and fatty acids of normal immature neutrophils: comparison with acute myeloblastic leukemia cells and normal neutrophils | Q40615176 | ||
| Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression | Q40968806 | ||
| Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection. | Q41610203 | ||
| Effects of prostaglandins E1, E2, and F2α on the growth of leukaemia cells in culture | Q44179582 | ||
| Antiproliferative effects of a non-beta-oxidizable fatty acid, tetradecylthioacetic acid, in native human acute myelogenous leukemia blast cultures | Q44194173 | ||
| Fast liquid chromatography-quadrupole linear ion trap-mass spectrometry analysis of polyunsaturated fatty acids and eicosanoids in human plasma | Q44203678 | ||
| Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages. | Q44816682 | ||
| High-Throughput Quantitative Lipidomics Analysis of Nonesterified Fatty Acids in Human Plasma | Q46547487 | ||
| Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity. | Q46662676 | ||
| The expression of cytosolic phospholipase A2 and biosynthesis of leukotriene B4 in acute myeloid leukemia cells | Q46919877 | ||
| Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality | Q48467683 | ||
| Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension. | Q50514016 | ||
| Revisiting the dyslipidemia associated with acute leukemia. | Q51055460 | ||
| Novel enzymatic abnormalities in AML and CML in blast crisis: elevated leucocyte leukotriene C4 synthase activity paralleled by deficient leukotriene biosynthesis from endogenous substrate. | Q53432603 | ||
| Metabolism of prostaglandin E2 by human HL-60 leukemia cells | Q68779651 | ||
| Metabolism of cyclooxygenase and lipoxygenase products by 15-prostaglandin dehydrogenase from human HL-60 leukemia cells | Q70368668 | ||
| Lipids of human leukocytes: relation to celltype | Q70912368 | ||
| Gastric vascular actions of prostanoids and the dual effect of arachidonic acid | Q71608324 | ||
| Mechanisms of inhibition of mouse myeloid leukemic cell differentiation by prostaglandin F2 alpha | Q72049338 | ||
| Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues | Q72335999 | ||
| Coenzyme Q protects cells against serum withdrawal-induced apoptosis by inhibition of ceramide release and caspase-3 activation | Q73565991 | ||
| Targeting leukemia's "fatty tooth" | Q86496846 | ||
| P921 | main subject | acute myeloid leukemia | Q264118 |
| P304 | page(s) | 105-114 | |
| P577 | publication date | 2017-03-08 | |
| P1433 | published in | BBA clinical | Q27725665 |
| P1476 | title | The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features | |
| P478 | volume | 7 |
| Q40175945 | A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B Cells |
| Q64967767 | A Role for Lipid Mediators in Acute Myeloid Leukemia. |
| Q57023071 | Alteration of Serum Free Fatty Acids are Indicators for Progression of Pre-leukaemia Diseases to Leukaemia |
| Q98154686 | Metabolic underpinnings of leukemia pathology and treatment |
| Q95837489 | Metabolomics in acute myeloid leukemia |
| Q92703906 | Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia |
Search more.